Man Group’s Antares Pharma, Inc. ATRS Stock Holding History

Man Group’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-137,100	Closed	-$562K	–	2531
2022 Q1	$562K	Buy	137,100 +50,200	+58%	+$182K	﹤0.01%	1541
2021 Q4	$310K	Buy	86,900 +51,500	+145%	+$180K	﹤0.01%	1670
2021 Q3	$129K	Buy	35,400 +17,500	+98%	+$70.8K	﹤0.01%	1798
2021 Q2	$78K	Buy	+17,900	New	+$72.9K	﹤0.01%	1872

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Man Group's ATRS Position: Q2 2022 in Review

Man Group sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 137,100 shares — an estimated $562K sold.

Man Group first reported a position in ATRS in Q2 2021 and held it in 4 quarters. The position peaked at $562K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Man Group reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Man Group sold 137,100 Antares Pharma, Inc. shares in Q2 2022, an estimated $562K.
Man Group first reported a position in Antares Pharma, Inc. in Q2 2021 and held it in 4 quarters.
Man Group's Antares Pharma, Inc. position peaked at $562K in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Man Group's 13F filing for Q2 2022, filed 15 Aug 2022.